The safety/modified intention-to-treat population included all patients that received inoculation of nelipepimut-S or placebo and was utilized for comparing rates of adverse events
The safety/modified intention-to-treat population included all patients that received inoculation of nelipepimut-S or placebo and was utilized for comparing rates of adverse events. compared to… Read More »The safety/modified intention-to-treat population included all patients that received inoculation of nelipepimut-S or placebo and was utilized for comparing rates of adverse events